Simplex Trading’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-77,000
| Closed | -$3.1M | – | 9230 |
|
|
2026
Q1 | $3.1M | Sell |
77,000
-148,700
| -66% | -$3.2M | ﹤0.01% | 1472 |
|
|
2025
Q4 | $5.67M | Buy |
225,700
+76,600
| +51% | +$1.8M | ﹤0.01% | 1190 |
|
|
2025
Q3 | $3.37M | Buy |
149,100
+5,000
| +3% | +$117K | ﹤0.01% | 1823 |
|
|
2025
Q2 | $2.49M | Buy |
144,100
+67,200
| +87% | +$1.24M | ﹤0.01% | 1912 |
|
|
2025
Q1 | $1.68M | Sell |
76,900
-244,800
| -76% | -$6.76M | ﹤0.01% | 2201 |
|
|
2024
Q4 | $10.3M | Buy |
321,700
+68,000
| +27% | +$2.04M | 0.01% | 1011 |
|
|
2024
Q3 | $7.32M | Sell |
253,700
-3,400
| -1% | -$126K | ﹤0.01% | 1232 |
|
|
2024
Q2 | $9.86M | Buy |
257,100
+147,600
| +135% | +$6.68M | 0.01% | 1024 |
|
|
2024
Q1 | $6.44M | Sell |
109,500
-231,100
| -68% | -$14.7M | ﹤0.01% | 1413 |
|
|
2023
Q4 | $20.4M | Sell |
340,600
-178,600
| -34% | -$9.06M | 0.01% | 718 |
|
|
2023
Q3 | $19.8M | Buy |
519,200
+345,000
| +198% | +$15.2M | 0.02% | 594 |
|
|
2023
Q2 | $15.9M | Sell |
174,200
-4,000
| -2% | -$345K | 0.01% | 671 |
|
|
2023
Q1 | $11.8M | Buy |
178,200
+27,700
| +18% | +$1.6M | 0.01% | 815 |
|
|
2022
Q4 | $7.78M | Buy |
150,500
+131,900
| +709% | +$7M | 0.01% | 973 |
|
|
2022
Q3 | $1.27M | Sell |
18,600
-26,100
| -58% | -$1.54M | ﹤0.01% | 2380 |
|
|
2022
Q2 | $2.02M | Buy |
44,700
+700
| +2% | +$31.9K | ﹤0.01% | 1856 |
|
|
2022
Q1 | $2.23M | Buy |
44,000
+41,000
| +1,367% | +$1.81M | ﹤0.01% | 1998 |
|
|
2021
Q4 | $141K | Sell |
3,000
-14,400
| -83% | -$567K | ﹤0.01% | 5694 |
|
|
2021
Q3 | $1.18M | Buy |
17,400
+1,400
| +9% | +$78.7K | ﹤0.01% | 2836 |
|
|
2021
Q2 | $1.01M | Buy |
16,000
+15,825
| +9,043% | +$817K | ﹤0.01% | 3104 |
|
|
2021
Q1 | $750K | Buy |
+175
| New | +$8.28K | ﹤0.01% | 2793 |
|
|
2020
Q3 | – | Sell |
-396
| Closed | -$1.29M | – | 7731 |
|
|
2020
Q2 | $1.29M | Buy |
396
+319
| +414% | +$10.2K | ﹤0.01% | 1896 |
|
|
2020
Q1 | $206K | Sell |
77
-224
| -74% | -$7.95K | ﹤0.01% | 3546 |
|
|
2019
Q4 | $921K | Buy |
301
+292
| +3,244% | +$8.08K | ﹤0.01% | 2167 |
|
|
2019
Q3 | $21K | Buy |
9
+7
| +350% | +$193 | ﹤0.01% | 5761 |
|
|
2019
Q2 | $5K | Buy |
+2
| New | +$41 | ﹤0.01% | 6433 |
|
Other funds holding APLS
Simplex Trading's APLS Position: Q2 2026 in Review
Simplex Trading sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 2,735 shares — an estimated $110K sold.
Simplex Trading first reported a position in APLS in Q2 2019 and held it in 19 quarters. The position peaked at $6.92M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- Simplex Trading reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 2,735 Apellis Pharmaceuticals shares in Q2 2026, an estimated $110K.
- Simplex Trading first reported a position in Apellis Pharmaceuticals in Q2 2019 and held it in 19 quarters.
- Simplex Trading's Apellis Pharmaceuticals position peaked at $6.92M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.